Paper41599183
Charge Effects: Influence of Surface Charge on Protein Corona Adsorption Behavior on Liposomal Formulations.
Chen Q and 7 others. Pharmaceutics, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Charge Effects: Influence of Surface Charge on Protein Corona Adsorption Behavior on Liposomal Formulations. Papers, record 41599183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41599183
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Charge Effects: Influence of Surface Charge on Protein Corona Adsorption Behavior on Liposomal Formulations.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82373800 | National Natural Science Foundation of China | PubMed | ||
| GDYWZJ2024001 | Open Program of Guangdong Provincial Key Laboratory of Pharmaceutical Preparations Research and Evaluation | PubMed | ||
| GXSWFZ202503 | Open Funding of Key Laboratory of Biological Molecular Medicine Research (Guangxi Medical University), Education Department of Guangxi Zhuang Autonomous Region | PubMed | ||
| 202102070001 | Science and Technology Projects in Guangzhou | PubMed |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28196309 | The Impact of Protein Corona Formation on the Macrophage Cellular Uptake and Biodistribution of Spherical Nucleic Acids. | Small | 2017 | https://conductscience.org/library/papers/28196309 | PubMed |
| 2 | 28137466 | Secondary structural alterations in glucoamylase as an influence of protein aggregation. | Int J Biol Macromol | 2017 | https://conductscience.org/library/papers/28137466 | PubMed |
| 3 | 37505047 | Protein Corona of Anionic Fluid-Phase Liposomes Compromises Their Integrity Rather than Uptake by Cells. | Membranes (Basel) | 2023 | https://conductscience.org/library/papers/37505047 | PubMed |
| 4 | 31021510 | Formation of a Monolayer Protein Corona around Polystyrene Nanoparticles and Implications for Nanoparticle Agglomeration. | Small | 2019 | https://conductscience.org/library/papers/31021510 | PubMed |
| 5 | 19473803 | Fluorescence spectral resolution of tryptophan residues in bovine and human serum albumins. | J Pharm Biomed Anal | 2009 | https://conductscience.org/library/papers/19473803 | PubMed |
| 6 | 40129488 | Mannosamine-Engineered Nanoparticles for Precision Rifapentine Delivery to Macrophages: Advancing Targeted Therapy Against Mycobacterium Tuberculosis. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/40129488 | PubMed |
| 7 | 35520163 | Conformational-transited protein corona regulated cell-membrane penetration and induced cytotoxicity of ultrasmall Au nanoparticles. | RSC Adv | 2019 | https://conductscience.org/library/papers/35520163 | PubMed |
| 8 | 34896446 | The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency. | J Control Release | 2022 | https://conductscience.org/library/papers/34896446 | PubMed |
| 9 | 40124340 | PD-L1 siRNA incorporation into a cationic liposomal tumor mRNA vaccine enhances cytotoxic T cell activation and prevents immune evasion. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40124340 | PubMed |
| 10 | 28336870 | Evidence of Protein Adsorption in Pegylated Liposomes: Influence of Liposomal Decoration. | Nanomaterials (Basel) | 2017 | https://conductscience.org/library/papers/28336870 | PubMed |
| 11 | 21693769 | Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis. | Ann Oncol | 2012 | https://conductscience.org/library/papers/21693769 | PubMed |
| 12 | 39170967 | Unraveling the impact of different liposomal formulations on the plasma protein corona composition might give hints on the targeting capability of nanoparticles. | Nanoscale Adv | 2024 | https://conductscience.org/library/papers/39170967 | PubMed |
| 13 | 36703558 | DOTAP: Structure, hydration, and the counterion effect. | Biophys J | 2023 | https://conductscience.org/library/papers/36703558 | PubMed |
| 14 | 9219267 | Improved DNA: liposome complexes for increased systemic delivery and gene expression. | Nat Biotechnol | 1997 | https://conductscience.org/library/papers/9219267 | PubMed |
| 15 | 41097578 | Lactoferrin-Loaded Liposomal Nanoparticles: Enhanced Intestinal Stability and Bioactivity for Mitigating Radiation-Induced Intestinal Injury. | Foods | 2025 | https://conductscience.org/library/papers/41097578 | PubMed |
| 16 | 34761907 | Correlating Corona Composition and Cell Uptake to Identify Proteins Affecting Nanoparticle Entry into Endothelial Cells. | ACS Biomater Sci Eng | 2021 | https://conductscience.org/library/papers/34761907 | PubMed |
| 17 | 29478769 | Study on the in situ aggregation of liposomes with negatively charged phospholipids for use as injectable depot formulation. | Colloids Surf B Biointerfaces | 2018 | https://conductscience.org/library/papers/29478769 | PubMed |
| 18 | 26348965 | Principles of nanoparticle design for overcoming biological barriers to drug delivery. | Nat Biotechnol | 2015 | https://conductscience.org/library/papers/26348965 | PubMed |
| 19 | 38803167 | Metabolic Modulation-Mediated Antibiotic and Immune Activation for Treatment of Chronic Lung Infections. | ACS Nano | 2024 | https://conductscience.org/library/papers/38803167 | PubMed |
| 20 | 38680315 | Impact of Lipid Composition on Vesicle Protein Adsorption: A BSA Case Study. | ACS Omega | 2024 | https://conductscience.org/library/papers/38680315 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42979943 | Liposome-based responsive MRI contrast agents. | Chem Commun (Camb) | 2026 | https://conductscience.org/library/papers/42979943 | PubMed |
| 42278297 | Liposome-Based Photodynamic Therapy for Breast Cancer: Innovations in Targeted Delivery, Combination Strategies, and Clinical Translation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278297 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41599183
GET https://conductscience.org/api/papers/v1/41599183/references?page=2